Correlation Between Gilead Sciences and Chugai Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Gilead Sciences and Chugai Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gilead Sciences and Chugai Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gilead Sciences and Chugai Pharmaceutical Co, you can compare the effects of market volatilities on Gilead Sciences and Chugai Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gilead Sciences with a short position of Chugai Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gilead Sciences and Chugai Pharmaceutical.
Diversification Opportunities for Gilead Sciences and Chugai Pharmaceutical
0.82 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Gilead and Chugai is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Gilead Sciences and Chugai Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Chugai Pharmaceutical and Gilead Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gilead Sciences are associated (or correlated) with Chugai Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Chugai Pharmaceutical has no effect on the direction of Gilead Sciences i.e., Gilead Sciences and Chugai Pharmaceutical go up and down completely randomly.
Pair Corralation between Gilead Sciences and Chugai Pharmaceutical
Given the investment horizon of 90 days Gilead Sciences is expected to generate 0.67 times more return on investment than Chugai Pharmaceutical. However, Gilead Sciences is 1.49 times less risky than Chugai Pharmaceutical. It trades about 0.22 of its potential returns per unit of risk. Chugai Pharmaceutical Co is currently generating about 0.05 per unit of risk. If you would invest 9,137 in Gilead Sciences on December 28, 2024 and sell it today you would earn a total of 1,979 from holding Gilead Sciences or generate 21.66% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Gilead Sciences vs. Chugai Pharmaceutical Co
Performance |
Timeline |
Gilead Sciences |
Chugai Pharmaceutical |
Gilead Sciences and Chugai Pharmaceutical Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Gilead Sciences and Chugai Pharmaceutical
The main advantage of trading using opposite Gilead Sciences and Chugai Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gilead Sciences position performs unexpectedly, Chugai Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chugai Pharmaceutical will offset losses from the drop in Chugai Pharmaceutical's long position.Gilead Sciences vs. Amgen Inc | Gilead Sciences vs. Merck Company | Gilead Sciences vs. AbbVie Inc | Gilead Sciences vs. Johnson Johnson |
Chugai Pharmaceutical vs. Scilex Holding | Chugai Pharmaceutical vs. Merck Company | Chugai Pharmaceutical vs. Johnson Johnson | Chugai Pharmaceutical vs. Pfizer Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume |